


To provide a high and stable income, with the prospect of capital and income growth over the long term.This Fund is made up of around 70% UK equities and 30% UK investment grade bonds, A and AA rated.
| Name | % Net Assets | 
|---|---|
| Royal Dutch Shell | 6.7% | 
| BP | 6.3% | 
| GlaxoSmithKline | 4.1% | 
| HSBC | 3.8% | 
| AstraZeneca | 3.6% | 
| Vodafone | 3.0% | 
| British American Tobacco | 2.9% | 
| Unilever | 2.4% | 
| BHP Billiton | 2.3% | 
| BG Group | 1.7% | 
| Key | % Net Assets | 
|---|---|
| 6.7% | |
| 6.3% | |
| 4.1% | |
| 3.8% | |
| 79.1% | 
| Date | 15-Dec-2017 | 
|---|---|
| NAV | 90.29p | 
| Currency | GBP | 
| Change | -0.48p | 
| % | -0.53% | 
| YTD change | 90.29p | 
| YTD % | n/a | 
| Fund Inception | 01/10/1994 | 
|---|---|
| Fund Manager | Jamie Streeter / James Illsley / Talib Sheikh | 
| TER | 1.68 (31-Jan-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £100 | 
| Savings | £100 | 
| Charges | |
|---|---|
| Initial | 3.50% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.07 | 
You are here: research